- Home
- ZYBT vs ECPG Comparison
ZYBT vs ECPG Comparison
Compare ZYBT & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYBT
- ECPG
- Stock Information
- Founded
- ZYBT 2004
- ECPG 1998
- Country
- ZYBT China
- ECPG United States
- Employees
- ZYBT N/A
- ECPG N/A
- Industry
- ZYBT
- ECPG Finance Companies
- Sector
- ZYBT
- ECPG Finance
- Exchange
- ZYBT NYSE
- ECPG Nasdaq
- Market Cap
- ZYBT 340.3M
- ECPG 806.1M
- IPO Year
- ZYBT 2025
- ECPG 1999
- Fundamental
- Price
- ZYBT $5.88
- ECPG $39.04
- Analyst Decision
- ZYBT
- ECPG Strong Buy
- Analyst Count
- ZYBT 0
- ECPG 3
- Target Price
- ZYBT N/A
- ECPG $62.67
- AVG Volume (30 Days)
- ZYBT 280.2K
- ECPG 248.9K
- Earning Date
- ZYBT 07-03-2025
- ECPG 08-06-2025
- Dividend Yield
- ZYBT N/A
- ECPG N/A
- EPS Growth
- ZYBT N/A
- ECPG N/A
- EPS
- ZYBT 0.03
- ECPG N/A
- Revenue
- ZYBT $25,531,367.00
- ECPG $1,380,750,000.00
- Revenue This Year
- ZYBT N/A
- ECPG $21.70
- Revenue Next Year
- ZYBT N/A
- ECPG $8.86
- P/E Ratio
- ZYBT $197.44
- ECPG N/A
- Revenue Growth
- ZYBT N/A
- ECPG 11.49
- 52 Week Low
- ZYBT $3.50
- ECPG $26.45
- 52 Week High
- ZYBT $14.30
- ECPG $51.77
- Technical
- Relative Strength Index (RSI)
- ZYBT N/A
- ECPG 48.17
- Support Level
- ZYBT N/A
- ECPG $40.29
- Resistance Level
- ZYBT N/A
- ECPG $41.56
- Average True Range (ATR)
- ZYBT 0.00
- ECPG 1.11
- MACD
- ZYBT 0.00
- ECPG -0.01
- Stochastic Oscillator
- ZYBT 0.00
- ECPG 33.51
About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.